SoClean to sell Itamar’s sleep apnea test

 - 
Friday, December 6, 2019

PETERBOROUGH, N.H., and CAESAREA, Israel – SoClean has exclusive rights to market and sell the WatchPAT ONE to the direct-to-consumer market in the U.S., subject to purchasing certain minimum quantities. “The collaboration is designed to overcome the barriers to sleep apnea testing and therapy solutions by enabling consumers to purchase remote sleep consultations and home-based sleep test using the WatchPAT One in the comfort of their own homes,” a press release states. Itamar Medical’s WatchPAT One is a disposable home sleep apnea test cleared by the U.S. Food and Drug Administration. SoClean will have exclusivity through any and all marketing and sales channels outside of healthcare providers and facilities. SoClean plans to announce further details on the arrangement in the first quarter of 2020.